These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17415793)

  • 1. A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on serotonin markers in Göttingen minipig brain.
    Cumming P; Møller M; Benda K; Minuzzi L; Jakobsen S; Jensen SB; Pakkenberg B; Stark AK; Gramsbergen JB; Andreasen MF; Olsen AK
    Synapse; 2007 Jul; 61(7):478-87. PubMed ID: 17415793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    Ricaurte GA; McCann UD; Szabo Z; Scheffel U
    Toxicol Lett; 2000 Mar; 112-113():143-6. PubMed ID: 10720723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging in human MDMA (Ecstasy) users.
    Cowan RL; Roberts DM; Joers JM
    Ann N Y Acad Sci; 2008 Oct; 1139():291-8. PubMed ID: 18991874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia.
    Rosa-Neto P; Olsen AK; Gjedde A; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):214-21. PubMed ID: 15266553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
    Yamauchi Y; Izumi T; Unemura K; Uenishi Y; Nakagawa T; Kaneko S
    Neurosci Lett; 2007 Nov; 428(2-3):72-6. PubMed ID: 17949903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain.
    Do J; Schenk S
    Addict Biol; 2013 May; 18(3):441-7. PubMed ID: 21955305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
    Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.
    McCann UD; Szabo Z; Scheffel U; Dannals RF; Ricaurte GA
    Lancet; 1998 Oct; 352(9138):1433-7. PubMed ID: 9807990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.
    White SR; Obradovic T; Imel KM; Wheaton MJ
    Prog Neurobiol; 1996 Aug; 49(5):455-79. PubMed ID: 8895996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.